Therefore, the purpose of our study is to explore the specific molecular mechanism of GpS treatment of SLE, so as to explore more targets of GpS in clinical treatment, expand the therapeutic field of GpS, and facilitate the subsequent development of other clinical drugs. Here, NBEAL2 is linked to systemic lupus erythematosus.